Abstract:Stem cell-based therapy is emerging as a promising strategy to treat end-stage heart failure, a leading cause of morbidity and mortality. Stem cells can be isolated from a variety of sources and exhibit unique characteristics that impact their potential therapeutic utility. The adult heart contains small populations of committed, multipotent cardiac stem cells (CSC), which are adapted to the cardiac microenvironment and participate in postnatal physiological and pathological cardiac renewal or repair. These cells can be isolated, expanded in culture, and administered therapeutically to improve cardiac function in the setting of heart failure. CSC can be differentiated into three distinct cardiovascular lineages and exhibit enhanced paracrine factor production and engraftment as compared with other types of mesenchymal stem cells, which in turn may translate into improved therapeutic efficacy. The cell surface marker expression and phenotype of these CSC, however, depends on the method of isolation, selection and propagation, which likely explains the variable experimental results obtained to date. Moreover, invasive procedures are required to obtain CSC from humans. Early trials using autologous CSC in patients with ischemic cardiomyopathy have demonstrated feasibility and safety, along with variable degrees of therapeutic efficacy in terms of enhancing myocardial viability and cardiac function. Further studies are needed to optimize methods of CSC isolation, manipulation and delivery. If fully realized, the potential of CSC therapy could fundamentally change the approach to the treatment of end-stage heart failure.

Human Pluripotent Stem Cell-Derived Cardiovascular Cells: From Developmental Biology to Therapeutic Applications

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy

Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery

Differentiation And Application Of Human Pluripotent Stem Cells Derived Cardiovascular Cells For Treatment Of Heart Diseases: Promises And Challenges

Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies

Perspective on Human Pluripotent Stem Cell-Derived Cardiomyocytes in Heart Disease Modeling and Repair

Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives

Generation, expansion, and differentiation of cardiovascular progenitor cells from human pluripotent stem cells.

Human pluripotent stem cell-based models of heart development and disease

Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes

Applications of Genetically Engineered Human Pluripotent Stem Cell Reporters in Cardiac Stem Cell Biology

Advances in the Generation of Constructed Cardiac Tissue Derived from Induced Pluripotent Stem Cells for Disease Modeling and Therapeutic Discovery

Pluripotent stem cell-based heart regeneration: from the developmental and immunological perspectives.

Human Pluripotent Stem Cell-Derived Cardiovascular Progenitors for Heart Regeneration

Modelling neurocardiac physiology and diseases using human pluripotent stem cells: current progress and future prospects

Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications.

Induced pluripotent stem cells and cardiovascular disease

Deciphering Congenital Heart Disease Using Human Induced Pluripotent Stem Cells

Application of Pluripotent Stem Cells in Cardiac Development and Disease Research

The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing